Background: The study aims to investigate the willingness of physicians for the coronavirus disease 2019 vaccination, factors contributing to their attitude, and the effects of vaccination on their mental health. It is conducted online with physicians between February 17 and March 17, 2021, corresponding to a period of at least 1 month after the first dosage.
Methods: Sociodemographic and professional characteristics are investigated along with coronavirus disease 2019 experiences. The Fear of Coronavirus Disease 2019 Scale, Attitudes Toward the Coronavirus Disease 2019 Vaccine, The Hospital Anxiety and Depression Scale, and Beck Hopelessness Scale are given to evaluate the effects on mental health.
Results: Among 578 participants, the total vaccination rate was 91.5% and the main reason for non-vaccination is being already infected by coronavirus disease 2019. Vaccination affected mental health positively in more than half of the participants (59.2% in the vaccinated group). Advanced age (odds ratio = 0.985, < .05), positive attitude toward vaccination (odds ratio = 0.918, < .001), and high fear of coronavirus disease 2019 (odds ratio = 0.937, = .001) were among the predictors of being positively affected by the vaccination. Fear of coronavirus disease 2019 was positively correlated with hopelessness ( = .239, < .001), depression ( = 0.387, < .001), and anxiety ( = 0.531, < .001). The negative thoughts about the vaccination were found to be correlated with hopelessness levels ( = -0.093, < .05).
Conclusions: Physicians have positive attitudes toward vaccination and vaccination has positive effects on their mental health. As vaccination is a key point during the fight against the coronavirus disease 2019 pandemic, studies on vaccination and its effects on mental health gained importance. The role of physicians in this regard is inevitable.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099624 | PMC |
| http://dx.doi.org/10.5152/pcp.2022.21287 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk factors for disease progression and clinical outcomes in patients with COVID-19 in Taiwan: a nationwide population-based cohort study.
BMC Pulm Med
January 2025
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei City, Taiwan.
Background: Since 2021, COVID-19 has had a substantial impact on global health and continues to contribute to serious health outcomes. In Taiwan, most research has focused on hospitalized patients or mortality cases, leaving important gaps in understanding the broader effects of the disease and identifying individuals at high risk. This study aims to investigate the risk factors for disease progression through a nationwide population-based cohort study on COVID-19 in Taiwan.
View Article and Find Full Text PDFCritical Management of Haemodynamically Unstable Acute Pulmonary Embolism in COVID-19.
Acta Med Indones
October 2024
Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia - Harapan Kita National Cardiovascular Center, Jakarta, Indonesia.
Increased thrombotic events that occur in up to one-third of patients with COVID-19 are predominantly pulmonary emboli (PE), which are associated with higher severity and increased mortality. Acute PE should therefore be one of the main differential diagnoses among patients with hemodynamic instability. Early treatment of such a condition with systemic thrombolysis remains the first line of treatment especially in patients with COVID-19, which hinders further invasive intervention.
View Article and Find Full Text PDFThe mediating role of health literacy for COVID-19 between preventive behaviors and quality of life.
Appl Nurs Res
February 2025
School of Gerontology and Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan.. Electronic address:
Background: The coronavirus disease 2019 (COVID-19) pandemic rapidly developed around the world. Plenty of health information about the virus was available from multiple media platforms, but such information was not always accurate. Identifying misinformation depends on an individual's health literacy.
View Article and Find Full Text PDFThe feasibility of using machine learning to predict COVID-19 cases.
Int J Med Inform
January 2025
School of Geography and the Environment, University of Oxford, South Parks Road, Oxford OX1 3QY, United Kingdom. Electronic address:
Background: Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, emerged as a global health crisis in 2019, resulting in widespread morbidity and mortality. A persistent challenge during the pandemic has been the accuracy of reported epidemic data, particularly in underdeveloped regions with limited access to COVID-19 test kits and healthcare infrastructure. In the post-COVID era, this issue remains crucial.
View Article and Find Full Text PDFEvaluating convalescent plasma therapy in severe COVID-19: a retrospective cohort study.
J Infect Dev Ctries
December 2024
Department of Pharmacology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Introduction: Convalescent plasma (CP) therapy is a form of passive immunization which has been used as a treatment for coronavirus disease 2019 (COVID-19). This study aims to evaluate the efficacy and safety of CP therapy in patients with severe COVID-19.
Methodology: In this retrospective cohort study, 50 patients with severe COVID-19 treated with CP at Shahid Beheshti Hospital, Kashan, in 2019 were evaluated.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!